Antiviral immunity, obesity and pulmonary fibrosis will be discussed by three Vanderbilt University researchers during a Cutting-Edge Discovery Lecture on Nov. 21. The lecture will begin at 4 p.m. in 208 Light Hall.
Understanding how RSV is transmitted, which strains dominate and how new strains emerge around the globe will guide better vaccine and anti-viral drug design.
Michelle Griffith, MD, recently received an award for her work building networks for and advocacy of telehealth.
Travis Osterman, DO, MS, has been awarded a Microsoft Investigator Fellowship.
VUIMC will be the first in the state to offer a minimally invasive, non-surgical alternative for patients with emphysema.